Zentiva
David Baumgarten currently serves as Digital Strategy Lead for OTC & Value Added Medicine at Zentiva and has held the position of OTC Marketing Manager since June 2023. As the Founder of Reflora Skin since September 2020, David combines entrepreneurial experience with a background in strategic communications and marketing. Previous roles include EXIST Business Startup Grant at Bundesministerium für Wirtschaft und Klimaschutz, Entrepreneur in Residence at Metch and LEO Innovation Lab, and Strategic Communications Advisor at Bertelsmann SE & Co. KGaA. David's career also features significant contributions at Rocket Internet SE as a Senior Consultant in Healthcare, and earlier roles in public relations at MODOMOTO and fischerAppelt. David's education includes a Bachelor's degree in Visual Communication from Universität der Künste Berlin and a Digital Marketing Course from Hyper Island, complemented by an Erasmus exchange at Danmarks Medie- og Journalisthøjskole.
This person is not in any offices
Zentiva
5 followers
Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.